- Should routine screening for celiac disease be considered before star…
Number of the records: 1  

Should routine screening for celiac disease be considered before starting interferon/ribavirin treatment in patients affected by chronic hepatitis C or not?

  1. SYS0077452
    LBL
      
    00000naa--2200000-a-4500
    005
      
    20250607143210.1
    008
      
    120608c2012----xo-----e------------eng--
    040
      
    $a BA006 $b slo
    041
    0-
    $a eng $b eng
    044
      
    $a xo $c SK
    100
    1-
    $7 sllk_us_auth*0025710 $a Nejad, M. R. $u Research Center for Gastroenterology and Liver Disease, Shahid Behesthi University of Medical Sciences, Tehran, Iran $4 aut
    242
    10
    $a Mal by byť zvážený rutinný skríning celiakie pred začatím liečby interferónom s ribavirínom u pacientov trpiacich chronickou hepatitídou C alebo nie? $y slo
    245
    10
    $a Should routine screening for celiac disease be considered before starting interferon/ribavirin treatment in patients affected by chronic hepatitis C or not? / $c Nejad MR, Alavian SM
    504
      
    $a Bibliogr. odkazy
    504
      
    $a Res. angl.
    650
    12
    $7 sllk_us_auth*d002446 $a celiakia $x etiológia $2 mesh
    650
    12
    $7 sllk_us_auth*d019698 $a hepatitída C, chronická $x farmakoterapia $2 mesh
    650
    12
    $7 sllk_us_auth*d016898 $a interferón alfa $x použitie terapeutické $2 mesh
    650
    22
    $7 sllk_us_auth*d012254 $a ribavirín $2 mesh
    700
    1-
    $7 sllk_us_auth*0025711 $a Alavian, S. M. $u Baqiyatallah Research Center for Gastroenterology and Liver Disease, Tehran, Iran $4 aut
    773
    0-
    $7 nnas $w sllk_us_cat*0076518 $t Bratislavské lekárske listy $g Vol. 113, no. 4 (2012), s. 251 $x 0006-9248 $d Bratislava : AEPress, 2012
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.